logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-21. Gender ratio by primary drug - ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2005 for countries supplying data [see all tables in this series...]

Part (iv) Gender ratio (ratio of males to females) among all clients entering inpatient treatment

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsBase (known status)
Bulgaria(1)6.45.02.03.5588
Czech Republic2.21.51.91.62.09.82.83.01755
Denmark(2)3.72.02.51.84.73.9406
Germany(3)3.78.43.60.54.04.03.15682
Ireland(4)2.39.93.61.77.5802
Greece(5)5.44.815.04.91637
Cyprus(6)7.7165
Luxembourg(7)3.51.90.32.0136
Hungary3.62.11.40.53.32.76.11.65246
Romania(8)4.11.54.30.92.33.42.21529
Slovakia(9)4.14.04.50.814.48.50.8769
Finland(10)2.42.21.85.04.11155
Sweden(11)2.74.22.31.98.06.13.42637
United Kingdom2.72.83.22.01.01.52.71.62762
Turkey(12)12.49.96.04.129.616.729.02050
Total3.74.82.20.73.58.18.22.62.7
Total base12440110133804088725583203247727319

Notes:

 (1) No female cases for cocaine and volatile substances; no cases for hallucinogens and other drugs. 

 (2) No cases for hallucinogens and volatile substances. 

 (3) No female cases for cannabis. 

 (4) No female cases for hallucinogens and other drugs; no cases for Volatile substances. 

 (5) No female cases for stimulants and other drugs; no cases for hallucinogens and volatile substances. 

 (6) No male cases for hypnotics; no female cases for cannabis and cocaine; no cases for hallucinogens, stimulants, volatile substances and other drugs. 

 (7) No cases for hallucinogens, hypnotics, volatile substances and other drugs. 

 (8) No cases for hallucinogens. 

 (9) No female cases for hallucinogens. 

 (10) No female cases for cocaine, hallucinogens and other drugs. 

 (11) No female cases for hallucinogens. 

 (12) No cases for hallucinogens. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - TDI - inpatient treatment centres. 

Page last updated: Monday, 12 November 2007